William A. Lee

5.3k total citations
45 papers, 2.3k citations indexed

About

William A. Lee is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, William A. Lee has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 13 papers in Molecular Biology and 13 papers in Virology. Recurrent topics in William A. Lee's work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (12 papers) and Porphyrin and Phthalocyanine Chemistry (6 papers). William A. Lee is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (12 papers) and Porphyrin and Phthalocyanine Chemistry (6 papers). William A. Lee collaborates with scholars based in United States, Belgium and Austria. William A. Lee's co-authors include Thomas C. Bruice, Kenneth C. Cundy, Gong-Xin He, Eugene Eisenberg, Tomáš Cihlář, Jeng‐Pyng Shaw, S. Swaminathan, Dennis V. Stynes, Andrew Mulato and Leo Gu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

William A. Lee

45 papers receiving 2.1k citations

Peers

Countries citing papers authored by William A. Lee

Since Specialization

Citations

This map shows the geographic impact of William A. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Lee more than expected).

Fields of papers citing papers by William A. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Lee. The network helps show where William A. Lee may publish in the future.

Co-authorship network of co-authors of William A. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Lee. A scholar is included among the top collaborators of William A. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Lee. William A. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bartholin Gland Cyst 2019 ·StatPearls ·William A. Lee, (unknown)	1
2	TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy 2018 ·Science Translational Medicine ·So‐Yon Lim, Christa E. Osuna, Peter Hraber, (unknown), Jeffrey M. Gerold, Tiffany Barnes, Srisowmya Sanisetty, Michael S. Seaman, Mark G. Lewis, Romas Geleziunas, Michael D. Miller, Tomáš Cihlář, William A. Lee, Alison L. Hill, James B. Whitney	116
3	Substituted imidazopyridines as potent inhibitors of HCV replication 2009 ·Journal of Hepatology ·Inge Vliegen, Jan Paeshuyse, Tine De Burghgraeve, Laura S. Lehman, Matthew Paulson, I‐hung Shih, Eric Mabery, (unknown), Erik De Clercq, Hans Reiser, (unknown), William A. Lee, Weidong Zhong, Steven Bondy, Gerhard Pürstinger, Johan Neyts	35
4	GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants 2007 ·Inge Vliegen, Jan Paeshuyse, Eric Mabery, Betty Peng, I‐hung Shih, Laura S. Lehman, Hélène Dutartre, Barbara Selisko, Bruno Canard, Steven Bondy, Winston C. Tse, Hans Reiser, Erik De Clercq, William A. Lee, Gerhard Puerstinger, Weidong Zhong, Johan Neyts	8
5	Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH 2006 ·Bioorganic & Medicinal Chemistry Letters ·William J. Watkins, James Chen, Aesop Cho, Lee S. Chong, N. Collins, Maria Fardis, Wei Huang, Magdeleine Hung, Thorsten Kirschberg, William A. Lee, Xiaohong Liu, (unknown), Jie Xu, (unknown), Jennifer Zhang	18
6	Perspectives on the development of acyclic nucleotide analogs as antiviral drugs 2006 ·Antiviral Research ·William A. Lee, John Martin	53
7	Evaluation of Oral Tenofovir Disoproxil Fumarate and Topical Tenofovir GS-7340 to Protect Infant Macaques Against Repeated Oral Challenges With Virulent Simian Immunodeficiency Virus 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Koen K. A. Van Rompay, Brian P. Kearney, (unknown), (unknown), (unknown), (unknown), William A. Lee, Norbert Bischofberger, Marta L. Marthas	49
8	Suppression of HIV-1 Protease Inhibitor Resistance by Phosphonate-mediated Solvent Anchoring 2006 ·Journal of Molecular Biology ·Tomáš Cihlář, Gong-Xin He, Xiaohong Liu, James Chen, Marcos Hatada, S. Swaminathan, Martin J. McDermott, Zhengyu Yang, Andrew Mulato, Xiaowu Chen, Stephanie A. Leavitt, Kirsten M. Stray, William A. Lee	47
9	Evaluation of Nucleoside Phosphonates and Their Analogs and Prodrugs for Inhibition of Orthopoxvirus Replication 2003 ·Antimicrobial Agents and Chemotherapy ·Kathy A. Keith, Michael J. M. Hitchcock, William A. Lee, Antonı́n Holý, Earl R. Kern	54
10	PHARMACOKINETICS OF SALICYLATE ESTER PRODRUGS OF CYCLIC HPMPC IN DOGS 2001 ·Nucleosides Nucleotides & Nucleic Acids ·Reza Oliyai, Murty N. Arimilli, Robert J. Jones, William A. Lee	8
11	Aryl Ester Prodrugs of Cyclic HPMPC. I: Physicochemical Characterization and In Vitro Biological Stability 1999 ·Pharmaceutical Research ·Reza Oliyai, Jeng‐Pyng Shaw, (unknown), Kenneth C. Cundy, Murty N. Arimilli, (unknown), William A. Lee	18
12	Biexponential Decomposition of a Neuraminidase Inhibitor Prodrug (GS-4104) in Aqueous Solution 1998 ·Pharmaceutical Research ·Reza Oliyai, Lung‐Chi Yuan, (unknown), S. Swaminathan, (unknown), William A. Lee	9
13	Oral Formulations of Adefovir Dipivoxil: In Vitro Dissolution and in Vivo Bioavailability in Dogs 1997 ·Journal of Pharmaceutical Sciences ·Kenneth C. Cundy, (unknown), Gary C. Visor, (unknown), (unknown), William A. Lee, Jeng‐Pyng Shaw	26
14	Metabolism and Pharmacokinetics of Novel Oral Prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in Dogs 1997 ·Pharmaceutical Research ·Jeng‐Pyng Shaw, (unknown), Reza Oliyai, William A. Lee, Murty N. Arimilli, Choung U. Kim, Kenneth C. Cundy	102
15	A Novel Oligodeoxynucleotide Inhibitor of Thrombin. II. Pharmacokinetics in the Cynomolgus Monkey 1995 ·Pharmaceutical Research ·William A. Lee, James A. Fishback, Jeng‐Pyng Shaw, (unknown), Linda C. Griffin, Kenneth C. Cundy	14
16	Optimization ofin VitroFlux Through Hairless Mouse Skin of Cidofovir, a Potent Nucleotide Analog 1995 ·Journal of Pharmaceutical Sciences ·(unknown), Richard H. Guy, William A. Lee, James A. Kennedy, Gary C. Visor, (unknown)	11
17	A Novel Oligodeoxynucleotide Inhibitor of Thrombin. I. In VitroMetabolic Stability in Plasma and Serum 1995 ·Pharmaceutical Research ·Jeng‐Pyng Shaw, James A. Fishback, Kenneth C. Cundy, William A. Lee	16
18	The Effects of Permeation Enhancers on the Surface Morphology of the Rat Nasal Mucosa: A Scanning Electron Microscopy Study 1990 ·Pharmaceutical Research ·(unknown), (unknown), William A. Lee	62
19	Bioavailability Improvement of Mycophenolic Acid Through Amino Ester Derivatization 1990 ·Pharmaceutical Research ·William A. Lee, Leo Gu, Andrew R. Miksztal, Nancy Chu, Kwan Leung, (unknown)	202
20	Therapeutic Model for Experimental Spinal Cord Injury in the Rat: I. Mortality and Motor Deficit 1987 ·PubMed ·(unknown), William A. Lee, Chung Y. Hsu, E. L. Hogan, Russell D. Cox, Andreas J. Gross	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact